Compare CCXI & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCXI | SANA |
|---|---|---|
| Founded | 2025 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 950.8M | 793.1M |
| IPO Year | 2025 | 2021 |
| Metric | CCXI | SANA |
|---|---|---|
| Price | $13.60 | $3.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.80 |
| AVG Volume (30 Days) | 1.6M | ★ 3.1M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.24 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.09 | $2.61 |
| 52 Week High | $19.69 | $6.55 |
| Indicator | CCXI | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 50.57 | 38.63 |
| Support Level | $12.85 | $3.00 |
| Resistance Level | $14.16 | $3.43 |
| Average True Range (ATR) | 0.66 | 0.21 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 76.17 | 18.52 |
Churchill Capital Corp XI is a blank check company.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.